Altium Capital Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-731,561
Closed -$469K 176
2021
Q2
$469K Hold
731,561
0.11% 122
2021
Q1
$688K Buy
731,561
+231,561
+46% +$256K 0.19% 114
2020
Q4
$495K Buy
+500,000
New +$378K 0.18% 85

Altium Capital Management's CHAQ.WS Position: Q3 2021 in Review

Altium Capital Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 731,561 shares — an estimated $469K sold.

Altium Capital Management first reported a position in CHAQ.WS in Q4 2020 and held it in 3 quarters. The position peaked at $688K in Q1 2021. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

  • Altium Capital Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
  • Altium Capital Management sold 731,561 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $469K.
  • Altium Capital Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q4 2020 and held it in 3 quarters.
  • Altium Capital Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $688K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Altium Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.